Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting crawled date : 2022 - 03 - 08 save search
Theseus Pharmaceuticals to Present Preclinical Data Characterizing Next-Generation Epidermal Growth Factor Receptor (EGFR) Inhibitors at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
THRX | $4.06 0.49% 0
|
|
| O: 2.4%
H: 8.76%
C: 4.68%
america als derm research preclinical cancer growth pre-clinical
Omega Therapeutics to Present Preclinical Data for OTX-2002 at the American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
OMGA | $2.42 -5.28% -5.58% 360K
|
|
| O: 2.36%
H: 0.0%
C: 0.0%
otx-2002 america research therapeutics preclinical cancer pre-clinical
Arcellx Announces Pre-Clinical Data Presentation for ACLX-002, a Novel CD123-targeted Universal CAR-T Cell Therapy for Relapsed or Refractory Acute Myeloid Leukemia at the American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
ACLX | $54.5 1.77% 1.74% 600K
|
|
| O: 2.8%
H: 3.41%
C: -6.98%
aclx-002 america myeloid leukemia car-t leukemia research presentation cel pre-clinical therapy cancer t-cell preclinical acute myeloid leukemia
Nuvalent to Present New Preclinical Data on ROS1-Selective Inhibitor NVL-520 and ALK-Selective Inhibitor NVL-655 at AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
NUVL | $62.97 -1.99% -2.03% 610K
|
|
| O: 2.01%
H: 7.27%
C: -2.9%
nvl-520 preclinical pre-clinical
Adagene Announces Four Poster Presentations on Robust Preclinical Pipeline of Antibody-Based Therapeutics at Upcoming American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 23:00) - globenewswire.com
ADAG | $2.53 -0.37% 1.8K
|
Manufacturing
|
| O: 1.25%
H: 8.84%
C: -2.24%
america pos research therapeutics presentation preclinical cancer antibody pre-clinical
Kura Oncology Announces Multiple Abstracts Accepted for Presentation at AACR Annual Meeting
Published: 2022-03-08 (Crawled : 23:00) - globenewswire.com
KURA | $17.66 -1.83% -1.87% 1.7M
|
Health Technology
|
| O: 0.8%
H: 6.28%
C: 3.54%
ces presentation
Genocea to Present Clinical and Preclinical Data at AACR Annual Meeting
Published: 2022-03-08 (Crawled : 23:00) - globenewswire.com
GNCA | $0.051
|
Health Technology
|
| O: 3.74%
H: 9.01%
C: 7.21%
preclinical pre-clinical
Gritstone Announces Three Presentations for Tumor-Specific Neoantigen (TSNA) Oncology Programs, GRANITE and SLATE, at the 2022 AACR Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
GRTS | $0.7446 -0.08% -0.08% 2.1M
|
Health Technology
|
| O: 4.63%
H: 3.79%
C: 0.84%
program presentation one
Zentalis Pharmaceuticals to Present New Clinical and Preclinical Data at the AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
ZNTL | $12.55 -1.26% -1.27% 680K
|
Health Technology
|
| O: 3.2%
H: 8.26%
C: 6.25%
als preclinical pre-clinical
Bolt Biotherapeutics to Present Updates for Three Preclinical Immuno-Oncology Pipeline Programs at AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
BOLT | $1.15 3.6% 3.48% 89K
|
|
| O: 3.38%
H: 13.07%
C: 11.44%
program therapeutics preclinical iot pre-clinical
IO Biotech Announces Acceptance of Abstract to be Presented at AACR Annual Meeting on April 8, 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
IOBT | $1.5 1.95% 180K
|
|
| O: -2.61%
H: 3.9%
C: -1.22%
ces biotech iot
Bio-Path Holdings to Present at the 2022 American Association for Cancer Research Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
BPTH | $4.26 31.48% 23.94% 83M
|
Health Technology
|
| O: 3.38%
H: 4.17%
C: 4.17%
america research cancer
Erasca Announces Six Poster Presentations at the 2022 AACR Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
ERAS | $1.795 -2.45% -2.51% 650K
|
|
| O: 1.57%
H: 4.31%
C: 3.1%
pos ces presentation
Kronos Bio’s Investigational CDK9 Inhibitor KB-0742 to be Featured in Four Preclinical Poster Presentations at American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
KRON | $1.01 -2.89% -2.97% 210K
|
Health Technology
|
| O: 2.13%
H: 6.85%
C: 6.25%
kb-0742 america pos research presentation preclinical cancer pre-clinical
Cogent Biosciences Announces Upcoming Presentations at AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
COGT | $6.605 1.15% 1.14% 1.1M
|
Health Technology
|
| O: 2.17%
H: 4.41%
C: 2.61%
presentation bioscience
Galaxy Gaming Announces its Meeting of Shareholders For 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
GLXZ | $1.31 57.78% 12K
|
Arts, Entertainment, and Recrea...
|
| O: 0.49%
H: 2.09%
C: 0.74%
ces
C4 Therapeutics to Present at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
CCCC | $6.91 0.58% 0.58% 1.1M
|
Health Technology
|
| O: 5.67%
H: 11.76%
C: 9.1%
america research therapeutics cancer
Iovance Biotherapeutics to Present at American Association for Cancer Research (AACR) 2022 Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 2.21%
H: 6.63%
C: 5.78%
america research therapeutics cancer iot
Olema Oncology Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
OLMA | $9.92 -7.38% -7.96% 760K
|
Health Technology
|
| O: 2.97%
H: 10.42%
C: 8.65%
america ema pos research presentation cancer
ORIC Pharmaceuticals Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
ORIC | $9.5 -2.66% -2.74% 590K
|
Health Technology
|
| O: 0.43%
H: 13.86%
C: 8.57%
america als research presentation cancer
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
OST | $0.499 21.38% 45.26% 1.9M
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.